45P The RevCAR T cell platform: A switchable and combinatorial therapeutic strategy for glioblastoma. (December 2022) - Mitwasi, N.; Hassan, H.; Arndt, C.; Loureiro, L.; Neuber, C.; Kegler, A.; Kubeil, M.; Toussaint, M.; Deuther-Conrad, W.; Bachmann, M.; Feldmann, A.